Doha: The guidelines for managing patients with chronic heart failure were discussed at the latest instalment of Weill Cornell Medicine-Qatar’s (WCM-Q) cardiology webinar series.
The series, titled ‘What Does the Non-Cardiologist Need to Know About Cardiology?’ is aimed at physicians, particularly those in primary care roles, who treat patients with common cardiac conditions in their clinics but who are not specialist cardiology consultants themselves. The series is presented by Dr. Islam Elgendy, assistant professor of medicine at WCM-Q, an interventional cardiologist and outcomes researcher.
Outlining the scope of the problem, Dr. Elgendy noted that more than six million people in the United States and more than 23 million worldwide have heart failure. There are approximately one million hospitalizations each year in the United States for heart failure and the risk increases with age, he said. Risk factors for heart failure are coronary heart disease, cigarette smoking, hypertension, low physical activity, being male, low educational attainment, being overweight, diabetes, and valvular heart disease, in that order.
Participants who joined the webinar learned how to summarize the guidelines for management of a range of common cardiac conditions in the outpatient setting. They also learned the indications of a number of common cardiac medications commonly prescribed by primary care physicians. In addition, the webinar featured a precis of the diagnosis and classification of different stages of heart failure and how to treat them. Dr. Elgendy then guided the participants through a detailed case study of a 68-year-old man with heart failure before concluding the session by taking questions from the audience.
The event was accredited locally by the Ministry of Public Health’s Department of Healthcare Professions – Accreditation Section and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
-Ends -
About Weill Cornell Medicine - Qatar
Weill Cornell Medicine - Qatar is a partnership between Cornell University and Qatar Foundation. It offers a comprehensive six-year medical program leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC), Aspetar Orthopedic and Sports Medicine Hospital, the Primary Health Care Corporation, the Feto Maternal Center, and Sidra Medicine, who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high quality health care to the Qatari population.
For more info, please contact:
Hanan Lakkis
Associate Director, Media and Publications
Weill Cornell Medicine - Qatar
Direct Line: +974 44928661
hyl2004@qatar-med.cornell.edu
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
